Natural hormone may offer obesity path beyond appetite suppression
A University of Oklahoma mouse study found FGF21 acts in a brain region also targeted by GLP-1 drugs, but human safety and effectiveness remain unproven
Read verified news on BetaVoices covering Metabolic health, with reporting, context, and related developments.
A University of Oklahoma mouse study found FGF21 acts in a brain region also targeted by GLP-1 drugs, but human safety and effectiveness remain unproven